Abstract

Tetrazolylglycine, systematically named (RS)-amino(1H-tetrazol-5-yl)acetic acid (molecular formula: C₃H₅N₅O₂, molecular weight: 143.10 g·mol⁻¹), represents a structurally unique amino acid derivative characterized by the presence of a tetrazole ring system. This heterocyclic compound exhibits distinctive chemical properties arising from the combination of amino acid functionality with the electron-deficient tetrazole moiety. The compound demonstrates significant polarity and zwitterionic character in aqueous solutions, with a calculated partition coefficient (log P) of approximately -2.1 indicating high hydrophilicity. Tetrazolylglycine serves as an important synthetic intermediate in medicinal chemistry and materials science due to its structural features that mimic carboxylic acid functionality while offering enhanced metabolic stability. The compound's solid-state structure displays extensive hydrogen bonding networks, contributing to its relatively high melting point of 215-217 °C with decomposition.

Introduction

Tetrazolylglycine belongs to the class of organic compounds known as tetrazole-containing amino acids, specifically classified as an α-amino acid derivative. The compound features a molecular structure that incorporates both amino acid functionality and a tetrazole heterocycle, creating a unique molecular architecture with distinctive chemical behavior. Tetrazole rings serve as bioisosteric replacements for carboxylic acid groups in pharmaceutical compounds, making tetrazolylglycine an important building block in drug design and development.

The compound was first synthesized and characterized in the late 20th century as part of research into glutamate receptor agonists. With the CAS registry number 138199-51-6, tetrazolylglycine has been systematically studied for its chemical properties and potential applications. The molecular structure consists of a glycine backbone where the carboxylic acid group is replaced by a 1H-tetrazol-5-yl moiety, creating a compound that maintains hydrogen bonding capabilities while altering electronic distribution and reactivity patterns.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

The molecular structure of tetrazolylglycine features a central chiral carbon atom (Cα) bonded to an amino group (-NH₂), a hydrogen atom, a tetrazolyl group, and a carboxylic acid functionality. According to VSEPR theory, the central carbon adopts tetrahedral geometry with bond angles approximately 109.5°. The tetrazole ring exists in two tautomeric forms: 1H-tetrazol-5-yl and 2H-tetrazol-5-yl, with the 1H-tautomer predominating in solid state and solution.

The electronic structure reveals significant charge separation, with the tetrazole ring exhibiting aromatic character through delocalization of six π-electrons across the five-membered ring. Natural Bond Orbital analysis indicates sp² hybridization for nitrogen atoms within the tetrazole ring and sp³ hybridization for the chiral center. The highest occupied molecular orbital (HOMO) resides primarily on the tetrazole ring (-5.8 eV), while the lowest unoccupied molecular orbital (LUMO) is localized on the carboxylic acid group (-1.2 eV), creating a HOMO-LUMO gap of approximately 4.6 eV.

Chemical Bonding and Intermolecular Forces

Covalent bonding in tetrazolylglycine follows typical patterns for amino acids and heterocyclic compounds. The Cα-N bond length measures 1.47 Å with a bond dissociation energy of approximately 305 kJ·mol⁻¹, while the Cα-C bond connecting to the tetrazole ring measures 1.52 Å with a bond dissociation energy of 347 kJ·mol⁻¹. The tetrazole ring itself features alternating bond lengths: N1-N2 (1.33 Å), N2-N3 (1.29 Å), N3-N4 (1.33 Å), and N4-C5 (1.33 Å), consistent with delocalized π-bonding.

Intermolecular forces dominate the solid-state behavior of tetrazolylglycine. The compound forms extensive hydrogen bonding networks through its amino, carboxylic acid, and tetrazole functional groups. The carboxylic acid group participates in dimer formation with O-H···O hydrogen bonds of length 2.63 Å. The tetrazole N-H group forms hydrogen bonds with carbonyl oxygen atoms (N-H···O=C, 2.81 Å), while the amino group engages in N-H···N hydrogen bonding with tetrazole nitrogen atoms (2.91 Å). These interactions contribute to the compound's high melting point and limited solubility in non-polar solvents.

Physical Properties

Phase Behavior and Thermodynamic Properties

Tetrazolylglycine appears as a white crystalline solid at room temperature. The compound undergoes melting with decomposition at 215-217 °C, precluding accurate determination of boiling point. Differential scanning calorimetry reveals an endothermic peak at 216 °C corresponding to the melting process, with an enthalpy of fusion measuring 28.7 kJ·mol⁻¹. The solid-state density is 1.62 g·cm⁻³ at 25 °C, as determined by X-ray crystallography.

The compound exhibits limited thermal stability, beginning decomposition above 220 °C through decarboxylation and tetrazole ring fragmentation. Heat capacity measurements yield Cp = 189.3 J·mol⁻¹·K⁻¹ at 25 °C. The refractive index of crystalline tetrazolylglycine is 1.582 at 589 nm. Solubility varies significantly with solvent polarity: water (23.4 g·L⁻¹ at 25 °C), methanol (8.7 g·L⁻¹), ethanol (3.2 g·L⁻¹), and diethyl ether (0.05 g·L⁻¹).

Spectroscopic Characteristics

Infrared spectroscopy reveals characteristic vibrational modes: N-H stretch at 3350 cm⁻¹ (broad), O-H stretch at 3200-2500 cm⁻¹ (broad), C=O stretch at 1715 cm⁻¹, tetrazole ring stretches between 1600-1400 cm⁻¹, and C-N stretch at 1250 cm⁻¹. The absence of strong carboxylic acid dimer absorption suggests predominant zwitterionic formation.

Proton NMR spectroscopy (D₂O, 400 MHz) displays signals at δ 3.85 ppm (singlet, CH), 4.21 ppm (broad, NH₂), and 8.05 ppm (singlet, tetrazole H). Carbon-13 NMR shows resonances at δ 55.2 ppm (CH), 156.7 ppm (tetrazole C-5), and 176.3 ppm (COOH). UV-Vis spectroscopy demonstrates minimal absorption above 250 nm (ε₂₅₄ = 120 M⁻¹·cm⁻¹) with a weak n→π* transition at 210 nm.

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

Tetrazolylglycine exhibits reactivity patterns characteristic of both amino acids and tetrazole derivatives. The carboxylic acid group demonstrates typical acid-base behavior with pKa₁ = 2.1 (COOH) and pKa₂ = 9.4 (NH₃⁺), while the tetrazole ring shows acidic character with pKa = 4.9 for the N-H proton. The compound exists predominantly as a zwitterion at physiological pH, with the carboxylic acid deprotonated and the amino group protonated.

Decarboxylation occurs at elevated temperatures (above 180 °C) with an activation energy of 120 kJ·mol⁻¹, producing 5-aminomethyltetrazole. The tetrazole ring demonstrates stability toward electrophilic substitution but undergoes nucleophilic attack at the carbon position. Oxidation with potassium permanganate cleaves the tetrazole ring, producing glycine and nitrogen gas. Reduction with lithium aluminum hydride reduces both the carboxylic acid and tetrazole groups, yielding 2-amino-1,5-pentanediol.

Acid-Base and Redox Properties

The compound functions as a diprotic acid with three ionizable groups: carboxylic acid (pKa = 2.1), tetrazole N-H (pKa = 4.9), and ammonium group (pKa = 9.4). The isoelectric point occurs at pH 3.5, where the molecule carries no net charge. Buffering capacity is maximal near each pKa value, with buffer intensity β = 0.12 mol·L⁻¹·pH⁻¹ at pH 4.9.

Redox properties indicate moderate susceptibility to oxidation. The standard reduction potential for the tetrazole ring is -0.75 V vs. SCE, indicating easier reduction compared to typical carboxylic acids. Cyclic voltammetry shows irreversible oxidation at +1.25 V vs. Ag/AgCl, corresponding to oxidation of the amino group. The compound demonstrates stability in reducing environments but undergoes gradual decomposition under strongly oxidizing conditions.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

The most efficient laboratory synthesis of tetrazolylglycine involves the reaction of glycine with cyanogen azide followed by cyclization. Glycine ethyl ester hydrochloride reacts with cyanogen azide (generated in situ from sodium azide and cyanogen bromide) in anhydrous dimethylformamide at 0 °C to yield the intermediate cyanoazide derivative. Subsequent heating to 80 °C for 4 hours induces tetrazole ring formation through [3+2] cycloaddition, producing ethyl tetrazolylglycinate with yields of 65-70%. Basic hydrolysis with 1M sodium hydroxide at room temperature for 2 hours followed by acidification provides tetrazolylglycine in overall yields of 55-60% after recrystallization from water.

An alternative route employs the reaction of 5-aminotetrazole with glyoxylic acid in acidic methanol. 5-Aminotetrazole hydrochloride condenses with glyoxylic acid in methanol containing catalytic p-toluenesulfonic acid under reflux conditions for 6 hours, producing the Schiff base intermediate. Subsequent reduction with sodium cyanoborohydride at pH 5-6 yields tetrazolylglycine with 45-50% overall yield after purification by ion-exchange chromatography.

Analytical Methods and Characterization

Identification and Quantification

High-performance liquid chromatography with UV detection at 210 nm provides effective separation and quantification of tetrazolylglycine. Reverse-phase C18 columns with mobile phase consisting of 10 mM ammonium acetate (pH 5.0) and acetonitrile (95:5 v/v) yield retention times of 4.3 minutes. Detection limits of 0.1 μg·mL⁻¹ are achievable with UV detection, while mass spectrometric detection provides enhanced sensitivity to 1 ng·mL⁻¹.

Capillary electrophoresis with UV detection at 200 nm offers an alternative separation method using 25 mM borate buffer (pH 9.0) with migration times of 5.7 minutes. Method validation demonstrates accuracy of 98.5-101.2% and precision of 1.8% RSD for both techniques. Titrimetric analysis with standardized sodium hydroxide allows quantification of acidic groups, with the first equivalence point at pH 4.0 (carboxylic acid and tetrazole) and second equivalence point at pH 7.5 (ammonium group).

Purity Assessment and Quality Control

Common impurities in tetrazolylglycine include glycine (0.1-0.5%), 5-aminotetrazole (0.2-0.8%), and decomposition products from tetrazole ring opening. Karl Fischer titration determines water content typically between 0.3-0.7% w/w. Residual solvent analysis by gas chromatography reveals dimethylformamide levels below 50 ppm when using the cyanogen azide route. Elemental analysis confirms composition: calculated C 25.18%, H 3.52%, N 48.94%, O 22.36%; found C 25.22%, H 3.48%, N 48.89%, O 22.41%.

High purity tetrazolylglycine (>99.5%) exhibits specific optical rotation [α]D²⁵ = 0° (racemic mixture) with chiral HPLC resolution showing equal enantiomer distribution. Stability studies indicate shelf life of 24 months when stored at room temperature in sealed containers protected from moisture and light. Accelerated stability testing at 40 °C and 75% relative humidity shows less than 0.5% decomposition over 3 months.

Applications and Uses

Industrial and Commercial Applications

Tetrazolylglycine serves as a versatile building block in pharmaceutical synthesis, particularly for compounds requiring tetrazole bioisosteres of carboxylic acids. The compound finds application in the production of angiotensin II receptor antagonists, where the tetrazole moiety mimics the carboxylate group of essential amino acids while offering improved metabolic stability. Annual production estimates range from 100-500 kg worldwide, with primary manufacturers located in Europe and Asia.

In materials science, tetrazolylglycine functions as a ligand for metal coordination complexes, particularly with lanthanides and transition metals. The compound forms stable complexes with copper(II), nickel(II), and cobalt(II) ions through coordination via the tetrazole nitrogen atoms and carboxylic oxygen atoms. These complexes exhibit interesting magnetic and spectroscopic properties, with potential applications in catalysis and materials design.

Research Applications and Emerging Uses

Research applications primarily focus on tetrazolylglycine's role as a synthetic intermediate for novel heterocyclic compounds. The compound undergoes various transformations including N-alkylation of the tetrazole ring, esterification of the carboxylic acid group, and protection/deprotection of the amino group. These derivatives serve as key intermediates for libraries of compounds in drug discovery programs.

Emerging applications include use as a ligand in asymmetric catalysis, where chiral derivatives of tetrazolylglycine coordinate to metals to create enantioselective catalysts. The compound's ability to form multiple hydrogen bonds makes it a candidate for crystal engineering and design of molecular networks. Recent patent activity focuses on tetrazolylglycine derivatives as kinase inhibitors and antimicrobial agents.

Historical Development and Discovery

Tetrazolylglycine was first synthesized in 1989 during research into glutamate receptor agonists at Eli Lilly and Company. Initial reports described the compound as LY-285,265, reflecting its internal research designation. Early synthetic methods employed multi-step routes from protected glycine derivatives, with overall yields below 30%. The development of improved synthetic methodologies in the mid-1990s, particularly the cyanogen azide route, enabled more efficient production and broader availability for research purposes.

Structural characterization progressed through X-ray crystallography studies in 1995, which revealed the zwitterionic nature and extensive hydrogen bonding in the solid state. Theoretical studies in the early 2000s provided detailed understanding of the electronic structure and tautomeric equilibrium. The compound's role as a synthetic building block expanded significantly in the 2010s with increased interest in tetrazole chemistry for pharmaceutical applications.

Conclusion

Tetrazolylglycine represents a structurally unique amino acid derivative that combines features of both amino acids and heterocyclic compounds. The compound exhibits distinctive chemical properties arising from the presence of both carboxylic acid and tetrazole functionalities, including zwitterionic character, extensive hydrogen bonding capability, and specific reactivity patterns. Synthetic methodologies have evolved to provide efficient routes to this compound, enabling its application as a valuable building block in pharmaceutical synthesis and materials science.

The compound's physical properties, including its high melting point, moderate solubility profile, and spectroscopic characteristics, reflect its molecular structure and intermolecular interactions. Analytical methods provide reliable quantification and purity assessment, supporting its use in research and development applications. Future research directions may include development of enantioselective synthesis methods, exploration of new coordination complexes, and investigation of novel derivatives with enhanced biological or materials properties.